Authors:
Ino, Y
Betensky, RA
Zlatescu, MC
Sasaki, H
Macdonald, DR
Stemmer-Rachamimov, AO
Ramsay, DA
Cairncross, JG
Louis, DN
Citation: Y. Ino et al., Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis, CLIN CANC R, 7(4), 2001, pp. 839-845
Authors:
Stemmer-Rachamimov, AO
Wiederhold, T
Nielsen, GP
James, M
Pinney-Michalowski, D
Roy, JE
Cohen, WA
Ramesh, V
Louis, DN
Citation: Ao. Stemmer-rachamimov et al., NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas, AM J PATH, 158(1), 2001, pp. 57-62
Authors:
Niida, Y
Stemmer-Rachamimov, AO
Logrip, M
Tapon, D
Perez, R
Kwiatkowski, DJ
Sims, K
MacCollin, M
Louis, DN
Ramesh, V
Citation: Y. Niida et al., Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomassuggests different genetic mechanisms for pathogenesis of TSC lesions, AM J HU GEN, 69(3), 2001, pp. 493-503
Authors:
Ino, Y
Zlatescu, MC
Sasaki, H
MacDonald, DR
Stemmer-Rachamimov, AO
Jhung, S
Ramsay, DA
von Deimling, A
Louis, DN
Cairncross, JG
Citation: Y. Ino et al., Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss, J NEUROSURG, 92(6), 2000, pp. 983-990
Authors:
Nielsen, GP
Stemmer-Rachamimov, AO
Shaw, J
Roy, JE
Koh, J
Louis, DN
Citation: Gp. Nielsen et al., Immunohistochemical survey of p16(INK4A) expression in normal human adult and infant tissues, LAB INV, 79(9), 1999, pp. 1137-1143
Authors:
Nielsen, GP
Stemmer-Rachamimov, AO
Ino, Y
Moller, MB
Rosenberg, AE
Louis, DN
Citation: Gp. Nielsen et al., Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation, AM J PATH, 155(6), 1999, pp. 1879-1884
Authors:
Stemmer-Rachamimov, AO
Ino, Y
Lim, ZY
Jacoby, LB
MacCollin, M
Gusella, JF
Ramesh, V
Louis, DN
Citation: Ao. Stemmer-rachamimov et al., Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2, J NE EXP NE, 57(12), 1998, pp. 1164-1167